Work

Brentuximab vedotin plus AVD for non-bulky limited stage Hodgkin lymphoma: A phase II trial.

Year: 2015

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2015.33.15_suppl.8505

Authors: Jeremy S. Abramson, Jon E. Arnason, Ann S. LaCasce, Robert Redd, Jeffrey A. Barnes, Lubomir Sokol, Robin Joyce, David Avigan, Donna S. Neuberg, Tak Takvorian, Ephraim P. Hochberg, Celeste M. Bello

Institutions: Massachusetts General Hospital, Beth Israel Deaconess Medical Center, Dana-Farber Cancer Institute, Moffitt Cancer Center

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2784824787

Cites:

Cited by: 14

Related to: 10